With disputes about the quality of exports on the rise, developing countries need to boost scientific capacity to win claims, says Joel D. Adriano.

The momentum for Open Access is unstoppable. Now the global science community must manage change to ensure poorer regions are not left behind.

Efforts to promote sustainable development must tap into technologies developed locally, driven by community needs and priorities.

It's time to move from debate to action with new mechanisms for funding research into diseases faced by developing countries.

Developing countries must be given all the scientific, technical and legal help they need to counter the growing trade in fake medicines.

Integrating modern and traditional medicine requires breaking down the legal and regulatory barriers that disadvantage the poor.

Patents on scientific knowledge may not be as useful — or valuable — as many claim them to be.

Commodity price rises are no substitute for long-term investment in infrastructure and capacity as a means of securing sustained development.

More efforts are needed to hold the leaders of the G8 nations to commitments made at their annual summit meetings.

Increasing access to affordable drugs in developing countries requires better government intervention, not less of it.

Although GM crops are controversial, they can still play an important role in meeting the world's food needs. But the controversies do highlight the need for a robust regulatory framework.

Last week’s agreement on provisions under which developing nations can gain access to cheap medicines should not lead to over-optimism about the outcome of broader trade talks later this month.

Opposition from the pharmaceutical industry to new rules on access to cheap drugs by developing nations has cast a cloud over political commitments to meeting the needs of the poor.